Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

Dendreon Corp. (DNDN)

-NasdaqGS
2.17 0.07(3.33%) Jul 23, 4:00PM EDT
|Pre-Market : 2.25 Up 0.08 (3.69%) 8:13AM EDT - Nasdaq Real Time Price
Prev Close:2.10
Open:2.10
Bid:2.22 x 300
Ask:2.23 x 900
1y Target Est:2.39
Beta:3.77
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:2.10 - 2.17
52wk Range:1.81 - 5.38
Volume:1,542,630
Avg Vol (3m):2,223,520
Market Cap:336.59M
P/E (ttm):N/A
EPS (ttm):-1.71
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DNDNUp 3.33%336.59M
NWBO350.61M
PGNX347.08M
SNY137.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.78
Quarterly EPS Est (Jun-14) :-0.20
Mean Recommendation*:3.6
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dendreon Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback